Wenxia Fan
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Comparative study of Fe(II)/sulfite, Fe(II)/PDS and Fe(II)/PMS for p-arsanilic acid treatment: Efficient organic arsenic degradation and contrasting total arsenic removal.
Journal: Water research
Published: September 30, 2023
Transformation mechanisms of iopamidol by iron/sulfite systems: Involvement of multiple reactive species and efficiency in real water.
Journal: Journal of hazardous materials
Published: October 21, 2021
Generation of an induced pluripotent stem cell line (GIBHi004-A) from a Parkinson's disease patient with mutant DJ-1/PARK7 (p.L10P).
Journal: Stem cell research
Published: March 05, 2020
Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9.
Journal: Stem cell research
Published: February 24, 2020
Generation of an induced pluripotent stem cell line (GIBHi003-A) from a Parkinson's disease patient with mutant PINK1 (p. I368N).
Journal: Stem cell research
Published: August 29, 2019
Generation of a PARK2 homozygous knockout induced pluripotent stem cell line (GIBHi002-A-1) with two common isoforms abolished.
Journal: Stem cell research
Published: August 22, 2019
Publisher Correction: NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming.
Journal: Nature cell biology
Published: June 17, 2018
Solving the puzzle of Parkinson's disease using induced pluripotent stem cells.
Journal: Experimental biology and medicine (Maywood, N.J.)
Published: June 19, 2014
Antioxidant supplementation reduces genomic aberrations in human induced pluripotent stem cells.
Journal: Stem cell reports
Published: March 26, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026